AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sept 2017 10:21 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...
Lilly takes on Pfizer, Novartis with new breast cancer drug data Ruby Khatun Khatun12 Sept 2017 10:01 AM ISTNEW YORK/MADRID: Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Pfizer gets patent for pneumonia vaccine in India Ruby Khatun Khatun23 Aug 2017 10:00 AM ISTNew Delhi: Multinational drug major Pfizer Inc said it has been granted patent in India for its vaccine Prevenar 13, used for protection against...
Big Relief to Pharma Companies: Delhi HC quashes ban on FDC drugs Meghna A Singhania1 Dec 2016 2:08 PM ISTNew Delhi: In a move that would bring great relief to pharmaceutical companies across the country, the Delhi High Court has set aside the government...
Exclusive: Pfizer weighs sale or spin off of consumer health unit - sources supriya kashyap kashyap10 Nov 2016 1:32 PM ISTn" style="transform: translate3d(0px, 0px, 0px);"U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division...
Consequences of break up of Pfizer Allergen inversion deal Geeta Sharma Sharma11 April 2016 9:33 AM ISTWith the US Treasuries new tax rules in place Pfizer- Allergan deal is off and the companies future on the hook. Pfizer's major drugs are coming off...
